Annual D&A
$29.06M$252.00K+0.87%
Summary
- Current Value
- As of today, EXEL annual D&A is $29.06M, up +0.87% on
- Historical Performance
- EXEL annual D&A is up +39.19% over the past 3 years, up +107.97% over the past 5 years
- All-Time High Comparison
- EXEL annual D&A is currently at its all-time high
- 3-Year Low Comparison
- EXEL annual D&A is +39.19% above its 3-year low of $20.88M reached on an earlier date
- Sector Comparison
- EXEL annual D&A is higher than 80.97% of companies in Healthcare sector
Depreciation & Amortization Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| $29.06M | +0.9% | +39.2% | +108.0% | +175.6% | ||
| $6.95M | -5.4% | -48.9% | +56.2% | +260.2% | ||
| $28.66M | -3.7% | +0.3% | +90.2% | +204.9% | ||
| Price | $53.23 | +23.5% | +173.5% | +127.3% | +509.0% | |
| $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | ||
| $1.54B | -6.7% | +7.6% | +75.6% | +454.3% | ||
| $1.34B | -4.2% | -0.6% | +59.7% | +2191.0% | ||
| Annual Revenue | $2.32B | +7.0% | +44.0% | +134.9% | +1153.8% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $29.06M | at high | |
| 5Y | $29.06M | at high | |
| All | $29.06M | at high |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $20.88M | N/A | +39.2% |
| 5Y | $13.97M | N/A | +108.0% |
| All | $731.00K | +3874.7% |
Depreciation & Amortization History
FAQ
What is the current annual D&A of EXEL?
As of today, EXEL annual D&A is $29.06M
What is 1-year change in EXEL annual D&A?
EXEL annual D&A is up +0.87% year-over-year
What is 3-year change in EXEL annual D&A?
EXEL annual D&A is up +39.19% over the past 3 years
How far is EXEL annual D&A from its all-time high?
EXEL annual D&A is currently at its all-time high
How does EXEL annual D&A rank versus sector peers?
EXEL annual D&A is higher than 80.97% of companies in Healthcare sector
When is EXEL next annual earnings release?
As of today, the next annual earnings release for EXEL has not been scheduled
Quarterly D&A
$6.95M$2,000.00+0.03%
Summary
- Current Value
- As of today, EXEL quarterly D&A is $6.95M, up +0.03% on
- Historical Performance
- EXEL quarterly D&A is down -5.41% year-over-year, down -48.86% over the past 3 years
- All-Time High Comparison
- EXEL quarterly D&A is currently -48.86% below its historical high of $13.59M set on
- 3-Year Low Comparison
- EXEL quarterly D&A is +190.42% above its 3-year low of -$7.68M reached on
- Sector Comparison
- EXEL quarterly D&A is higher than 78.74% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| $6.95M | +0.0% | -5.4% | -48.9% | +56.2% | ||
| $29.06M | – | +0.9% | +39.2% | +108.0% | ||
| $28.66M | -1.4% | -3.7% | +0.3% | +90.2% | ||
| Price | $53.23 | +25.7% | +23.5% | +173.5% | +127.3% | |
| $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | ||
| $400.35M | +13.1% | +1.1% | +8.6% | +49.0% | ||
| $339.52M | +1.0% | -2.8% | -7.1% | +29.8% | ||
| Quarterly Revenue | $610.81M | +2.0% | +10.0% | +49.4% | +126.0% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $7.42M | -6.4% | |
| 3Y | $13.59M | N/A | -48.9% |
| 5Y | $13.59M | -48.9% | |
| All | $13.59M | -48.9% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $6.95M | +0.0% | |
| 3Y | -$7.68M | +190.4% | |
| 5Y | -$7.68M | +190.4% | |
| All | -$7.68M | +190.4% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of EXEL?
As of today, EXEL quarterly D&A is $6.95M
What is EXEL quarterly D&A most recent change?
EXEL quarterly D&A was up +0.03% on March 1, 2026
What is 1-year change in EXEL quarterly D&A?
EXEL quarterly D&A is down -5.41% year-over-year
How far is EXEL quarterly D&A from its all-time high?
EXEL quarterly D&A is currently -48.86% below its historical high of $13.59M set on March 31, 2023
How does EXEL quarterly D&A rank versus sector peers?
EXEL quarterly D&A is higher than 78.74% of companies in Healthcare sector
When is EXEL next earnings release?
The next earnings release for EXEL is on
TTM D&A
$28.66M$397.00K-1.37%
Summary
- Current Value
- As of today, EXEL TTM D&A is $28.66M, down -1.37% on
- Historical Performance
- EXEL TTM D&A is down -3.74% year-over-year, up +0.25% over the past 3 years
- All-Time High Comparison
- EXEL TTM D&A is currently -10.56% below its historical high of $32.04M set on
- 3-Year Low Comparison
- EXEL TTM D&A is +128.37% above its 3-year low of $12.55M reached on
- Sector Comparison
- EXEL TTM D&A is higher than 79.24% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| $28.66M | -1.4% | -3.7% | +0.3% | +90.2% | ||
| $29.06M | – | +0.9% | +39.2% | +108.0% | ||
| $6.95M | +0.0% | -5.4% | -48.9% | +56.2% | ||
| Price | $53.23 | +25.7% | +23.5% | +173.5% | +127.3% | |
| -$618.22M | -219.2% | -220.0% | -226.6% | -285.8% | ||
| TTM Revenue | $2.38B | +2.4% | +3.3% | +42.8% | +130.4% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $29.78M | N/A | -3.8% |
| 3Y | $32.04M | -10.6% | |
| 5Y | $32.04M | -10.6% | |
| All | $32.04M | -10.6% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $28.66M | at low | |
| 3Y | $12.55M | +128.4% | |
| 5Y | $12.55M | +128.4% | |
| All | $440.00K | +6413.2% |
TTM D&A History
FAQ
What is the current TTM D&A of EXEL?
As of today, EXEL TTM D&A is $28.66M
What is EXEL TTM D&A most recent change?
EXEL TTM D&A was down -1.37% on March 1, 2026
What is 1-year change in EXEL TTM D&A?
EXEL TTM D&A is down -3.74% year-over-year
How far is EXEL TTM D&A from its all-time high?
EXEL TTM D&A is currently -10.56% below its historical high of $32.04M set on June 30, 2023
How does EXEL TTM D&A rank versus sector peers?
EXEL TTM D&A is higher than 79.24% of companies in Healthcare sector
When is EXEL next earnings release?
The next earnings release for EXEL is on
Data Sources & References
- EXEL Official Website www.exelixis.com
- EXEL Profile on Yahoo Finance finance.yahoo.com/quote/EXEL
- EXEL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/exel